IVAO Index
308,58 (14,30%)
How does this work? Site map Contacts Database
Ru
IVAO Index
308,58 (14,30%)
МЕНЮ
Translate Page Original Page
Home
Medicine and Health
Current Clinical Trials
Cancers and Other Neoplasms
Breast Neoplasms

Breast Neoplasms

1.
Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer
Прекращено
  • Therapy: bivatuzumab mertansine
Site Map